Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
70 participants
OBSERVATIONAL
2020-03-30
2020-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objective: The objective of the study was to investigate how surgical wards in Poland are managing during the COVID-19 pandemic.
Design, Setting and Participants: An anonymous, online survey was designed and published on the official website of The Association of Polish Surgeons. Data was collected between March the 30th and April the 6th of 2020. After data analysis responders were divided into two groups: Group 1 (responders currently working in a "COVID-19-dedicated" hospital) and Group 2 (responders currently working in "non-COVID-19-dedicated" hospital). The study group included Polish surgeons and surgery residents working in surgical departments during pandemic.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Patient Outcome of Cardiac Surgery During the COVID-19 Pandemic
NCT04389463
The Effect of COVID-19 Infection on Post-operative Complications
NCT05677815
Perioperative Complications Linked to COVID-19 History in Elective Cardiac Surgery Patients
NCT05752162
The Impact of the COVID-19 Pandemic on the Patient in Need of an Intervention
NCT05736822
Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg)
NCT04323644
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Responders currently working in a "COVID-19-dedicated" hospital, which was transformed by Polish Ministry of Health during SARS-CoV-2 pandemic into institution designated only for SARS-CoV-2 patients, including those developing symptoms and quarantined.
No intervention (survey study for medical doctors).
No intervention
Group 2
Responders currently working in "non-COVID-19-dedicated" hospital.
No intervention (survey study for medical doctors).
No intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention (survey study for medical doctors).
No intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
25 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jagiellonian University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tomasz Stefura
Reasearch Associate, PhD student at 2nd Department of General Surgery, Principal Investigator, Medical Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
2nd Department of General Surgery, Jagiellonian University Medical College
Krakow, MaĆopolska, Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1072.6120.103.2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.